Invivyd (IVVD) Return on Equity [ROE] (2021 - 2026)
Invivyd's Return on Equity [ROE] came in at -39.97% for Q2 2026, up 194.25 percentage points from -234.22% a year earlier.
Powered by 
Analysis
Invivyd (IVVD) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Invivyd's Return on Equity [ROE] was -35.95%, up 108.43 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of +56.14 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -144.38% in FY2024 (-64.62 pp), -79.77% in FY2023 (-25.49 pp), -54.27% in FY2022 (+37.82 pp) and -92.09% in FY2021.
- The five-year range for quarterly Return on Equity [ROE] is -242.77% (Q1 2025) to -33.21% (Q4 2025).
- Year-over-year, Return on Equity [ROE] increased in three of the last seven quarters, with an average year-over-year change of +2.98 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2025 (a gain of 201.53 percentage points), and the weakest in Q3 2024 (a drop of 139.70 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Invivyd | 168.01 Mn | -487.88 Mn | 13.01 Mn | -55.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.88% |
| Mar 31, 2026 | -34.92% |
| Dec 31, 2025 | -31.39% |
| Sep 30, 2025 | -88.16% |
| Jun 30, 2025 | -227.28% |
| Mar 31, 2025 | -234.57% |
| Dec 31, 2024 | -225.50% |
| Sep 30, 2024 | -201.21% |
| Jun 30, 2024 | -127.74% |
| Mar 31, 2024 | -116.14% |
| Dec 31, 2023 | -93.58% |
| Sep 30, 2023 | -64.24% |
| Jun 30, 2023 | -57.61% |
| Mar 31, 2023 | -51.58% |
| Dec 31, 2022 | -65.88% |
| Sep 30, 2022 | -70.62% |
| Jun 30, 2022 | -67.50% |
| Mar 31, 2022 | -56.76% |
| Dec 31, 2021 | -38.08% |
| Sep 30, 2021 | -85.58% |
API Access
Invivyd Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IVVD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();